Radiation Dose-escalation Trial for Glioblastomas with 3D-conformal Radiotherapy
![]() |
Cho, Jae-Ho
(Departments of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine)
Lee, Chang-Geol (Departments of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) Kim, Kyoung-Ju (Departments of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) Bak, Jin-Ho (Departments of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) Lee, Se-Byeoung (Departments of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) Cho, Sam-Ju (Departments of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) Shim, Su-Jung (Su Departments of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) Yoon, Dok-Hyun (Departments of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) Chang, Jong-Hee (Departments of Neurosurgery, Yonsei University College of Medicine) Kim, Tae-Gon (Departments of Neurosurgery, Yonsei University College of Medicine) Kim, Dong-Suk (Departments of Neurosurgery, Yonsei University College of Medicine) Suh, Chang-Ok (Departments of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) |
1 | Simpson WJ, Platts ME. Fractionation study in the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1976;1:639-644 DOI PUBMED ScienceOn |
2 | Scally LT, Lin C, Beriwal S, Brady LW. Brain, Brain Stem, andCerebellum. In: Perez CA, Brady LW, eds. Principles and Practice of Radiation Oncology. 2nd ed. Philadelphia, PA: Lippincott Co. 1992:97-113 |
3 | Purdy JA. 3D treatment planning and intensity-modulated radiation therapy. Oncology (Huntingt) 1999;13:155-168 |
4 | Kinsella TJ, Collins J, Rowland J, et al. Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme. J Clin Oncol 1988;6:871-879 PUBMED |
5 | Coffey RJ, Lunsford LD, Taylor FH. Survival after stereotactic biopsy of malignant gliomas. Neurosurgery 1988;22:465-473 DOI PUBMED |
6 | Garden AS, Maor MH, Yung WK, et al. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol 1991;20:99-110 DOI ScienceOn |
7 | Chan JL, Lee SW, Fraass BA, et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 2002;20:1635-1642 DOI ScienceOn |
8 | Lee SW, Fraass BA, Marsh LH, et al. Patterns of failure following high-dose 3-D conformal radiotherapy for highgrade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys 1999;43:79-88 DOI PUBMED ScienceOn |
9 | Cho H, Choi Y. Optimal radiation therapy field for malignant astrocytoma and glioblastoma multiforme. J Kor Soc Ther Radiol Oncol 2002;20:199-205 |
10 | Raaphorst GP, Feeley MM, Da Silva VF, Danjoux CE, Gerig LH. A comparison of heat and radiation sensitivity of three human glioma cell lines. Int J Radiat Oncol Biol Phys 1989;17:615-622 DOI PUBMED ScienceOn |
11 | Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 2002;52:6-13 DOI PUBMED ScienceOn |
12 | Hasegawa M, Niibe H, Mitsuhashi N, et al. Hyperfractionated and hypofractionated radiation therapy for human malignant glioma xenograft in nude mice. Jpn J Cancer Res 1995;86:879-884 DOI PUBMED |
13 | Jeremic B, Grujicic D, Antunovic V, Djuric L, Shibamoto Y. Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II study. Am J Clin Oncol 1995; 18:449-453 DOI PUBMED ScienceOn |
14 | Chang CH, Horton J, Schoenfeld D, et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 1983;52:997-1007 DOI ScienceOn |
15 | Werner-Wasik M, Scott CB, Nelson DF, et al. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. Cancer 1996;77:1535-1543 DOI ScienceOn |
16 | Loeffler JS, Alexander E 3rd, Hochberg FH, et al. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys 1990;19:1455-62 DOI PUBMED ScienceOn |
17 | Kapp DS, Wagner FC, Lawrence R. Glioblastoma multiforme: treatment by large dose fraction irradiation and metronidazole. Int J Radiat Oncol Biol Phys 1982;8:351-345 DOI PUBMED ScienceOn |
18 | Payne DG, Simpson WJ, Keen C, Platts ME. Malignant astrocytoma: hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial. Cancer 1982;50:2301-2306 DOI ScienceOn |
19 | Curran WJ Jr, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993;85:704-710 DOI ScienceOn |
20 | Walker MD, Alexander E Jr, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 1978;49: 333-343 DOI PUBMED |
21 | Chang SK, Suh CO, Lee SW, Keum KC, Kim GE. Analysis of prognostic factors in glioblastoma multiforme. J Kor Soc Ther Radiol Oncol 1996;14:181-189 |
22 | Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980;30:907-911 DOI PUBMED |
23 | Andreou J, George AE, Wise A, et al. CT prognostic criteria of survival after malignant glioma surgery. AJNR Am J Neuroradiol 1983;4:488-490 PUBMED |
24 | Mehta MP, Masciopinto J, Rozental J, et al. Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 1994;30:541-549 DOI PUBMED ScienceOn |
25 | Andersen AP. Postoperative irradiation of glioblastomas. Resultsin a randomized series. Acta Radiol Oncol Radiat Phys Biol 1978;17:475-484 PUBMED |
26 | Shin KH, Urtasun RC, Fulton D, et al. Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report. Cancer 1985;56:758-760 DOI ScienceOn |
27 | Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989;16:1405-1409 DOI PUBMED ScienceOn |
28 | Walker MD, Strike TA, Sheline GE. An analysis of doseeffect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5:1725-1731 DOI PUBMED ScienceOn |
29 | Shin KH, Muller PJ, Geggie PH. Superfractionation radiation therapy in the treatment of malignant astrocytoma. Cancer 1983;52:2040-2043 DOI ScienceOn |
30 | Marks JE, Wong J. The risk of cerebral radionecrosis in relation to dose, time and fractionation. A follow-up study. Prog Exp Tumor Res 1985;29:210-218 |
31 | Bentzen SM, Overgaard J, Thames HD, et al. Clinical radiobiology of malignant melanoma. Radiother Oncol 1989;16:169-182 DOI ScienceOn |
32 | Tamura M, Nakamura M, Kunimine H, Ono N, Zama A, Hayakawa K, Niibe H. Large dose fraction radiotherapy in the treatment of glioblastoma. J Neurooncol 1989;7:113-119 DOI PUBMED |
33 | Deutsch M, Green SB, Strike TA, et al. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 1989;16:1389-1396 DOI PUBMED ScienceOn |
![]() |